Consulting - Evaluating population-level outcomes in Chronic Lymphocytic leukemia in the era of novel therapies using the SEER registry
22 Mar 2024
Reading time ~1 minute
Project Overview
This consulting project focused on evaluating population-level outcomes in Chronic Lymphocytic Leukemia using the SEER registry, amid novel therapies. The aim was to better understand survival benefits and impacts among different demographics.
We also published a paper related to this study, Evaluating population-level outcomes in Chronic Lymphocytic leukemia in the era of novel therapies using the SEER registry. View Publication